ProCE Banner Activity

The Evolving Landscape of Frontline EGFR TKIs

Slideset Download
Review the latest evidence for optimal use of first-line agents in the management of EGFR­-mutated advanced NSCLC.

Released: September 27, 2018

Expiration: September 26, 2019

No longer available for credit.

Share

Faculty

Heather Wakelee

Heather Wakelee, MD

Associate Professor of Medicine, Oncology
Department of Medicine/Oncology
Stanford University/Stanford Cancer Institute
Stanford, California

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

This activity is supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Heather Wakelee, MD

Associate Professor of Medicine, Oncology
Department of Medicine/Oncology
Stanford University/Stanford Cancer Institute
Stanford, California